乳房生検の市場規模、シェア、成長分析、製品別、適応症別、エンドユーザー別、地域別- 産業予測、2024～2031年

乳房生検の世界市場規模は2022年に8億4,210万米ドルとなり、予測期間（2024～2031年）のCAGRは8.2%で、2023年の9億1,115万米ドルから2031年には17億1,163万米ドルに成長する見通しです。

世界の乳房生検市場は、乳がん罹患率の上昇と早期発見の重要性に対する意識の高まりにより、大きな成長を遂げています。この拡大に拍車をかけている主な要因には、低侵襲手術への選択の高まりと、画像診断および生検技術の技術的進歩があります。同市場には、コアニードル、吸引補助、細針吸引などさまざまな生検法があり、精度を高めるために画像ガイド下生検への傾向が高まっています。自動化システムやハンドヘルドツールなどの生検装置の革新により、手技の効率と患者の快適性が向上しています。北米は乳がん罹患率が高く、ヘルスケアインフラがしっかりしているため市場をリードしていますが、アジア太平洋とラテンアメリカの新興国は、より良いヘルスケアへの投資と乳がん検診に対する意識の高まりに後押しされ、急成長が見込まれています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2023年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

乳房生検の市場規模：製品別& CAGR（2024-2031）

• 市場概要
• 生検針
  • コアニードル
  • 細針吸引針
• MRIガイド下生検システム
• 超音波ガイド下乳房生検システム
  • 2Dマンモグラフィ超音波スキャンシステム
  • 3D Bモードマンモグラフィ超音波スキャンシステム
• 吸引補助装置
• ガイドワイヤー
• 乳房生検マーカー

乳房生検の市場規模：適応症別& CAGR（2024-2031）

• 市場概要
• 複雑な嚢胞
• 固形腫瘤
• 疑わしい固形腫瘤
• 疑わしい微小石灰化

乳房生検の市場規模：エンドユーザー別& CAGR（2024-2031）

• 市場概要
• 病院
• 専門クリニック
• がん研究機関

乳房生検の市場規模：地域別& CAGR（2024-2031）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2023年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2021-2023）

主要企業プロファイル

• Hologic, Inc.（USA）
• Danaher Corporation（USA）
• Becton, Dickinson and Company（BD）（USA）
• Argon Medical Devices（USA）
• Merit Medical Systems（USA）
• Menarini-Silicon Biosystems（Italy）
• Guardant Health, Inc.（USA）
• NeoGenomics（USA）
• Sysmex Inostics（Germany）
• Ethicon Endo-Surgery, Inc.（USA）
• C. R. Bard, Inc.（USA）
• Leica Biosystems Nussloch GmbH（Germany）
• Encapsule Medical Devices LLC（USA）
• Intact Medical Corporation（USA）
• Galini SRL（Italy）
• Cook Medical Incorporated（USA）
• Medtronic plc（Ireland）
• Devicor Medical Products, Inc.（USA）
• Carestream Health, Inc.（USA）
• Planmed Oy（Finland）

結論と推奨事項

Global Breast Biopsy Market size was valued at USD 842.1 million in 2022 and is poised to grow from USD 911.15 million in 2023 to USD 1711.63 million by 2031, growing at a CAGR of 8.2% during the forecast period (2024-2031).

The global breast biopsy market is experiencing significant growth, driven by rising breast cancer incidence and increased awareness of the importance of early detection. Key factors fueling this expansion include technological advancements in imaging and biopsy techniques, alongside a growing preference for minimally invasive procedures. The market features a variety of biopsy methods, including core needle, vacuum-assisted, and fine needle aspiration, with an increasing trend toward image-guided biopsies for enhanced accuracy. Innovations in biopsy devices, such as automated systems and handheld tools, are improving procedural efficiency and patient comfort. While North America leads the market due to high breast cancer prevalence and robust healthcare infrastructure, emerging economies in Asia-Pacific and Latin America are anticipated to grow rapidly, propelled by better healthcare investment and heightened awareness of breast cancer screening.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Breast Biopsy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Breast Biopsy Market Segmental Analysis

Global Breast Biopsy Market is segmented by product, indication, end user and region. Based on product, the market is segmented into biopsy needles, MRI guide biopsy systems, ultrasound guided breast biopsy system, vacuum assisted devices, guide wire and breast biopsy markers. Based on indication, the market is segmented into complex cysts, solid mass, suspicious solid mass and suspicious micro calcifications. Based on end user, the market is segmented into hospitals, specialty clinics and cancer research institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Breast Biopsy Market

A primary factor propelling the Global Breast Biopsy Market is the rising incidence of breast cancer across the globe. As one of the most frequently diagnosed cancers, breast cancer's prevalence has been on the upswing, amplifying the need for effective early detection and intervention strategies. This increasing cancer burden has heightened the focus on accurate diagnosis, leading to a surge in demand for breast biopsy procedures. Consequently, the necessity for reliable diagnostic methods to identify breast irregularities and facilitate prompt treatment has significantly spurred growth in the breast biopsy market, reflecting a critical aspect of contemporary healthcare advancements.

Restraints in the Global Breast Biopsy Market

One significant limitation affecting the Global Breast Biopsy Market is the risk of false-negative and false-positive results. Although breast biopsies are essential for accurate breast cancer diagnosis, there is a chance that these procedures might yield incorrect findings. False-negative results may arise when cancerous cells are not identified, resulting in delayed diagnoses or overlooked cases. Conversely, false-positive results can prompt unnecessary anxiety, leading to additional tests or invasive procedures for patients. These issues surrounding diagnostic accuracy can diminish trust in the reliability of breast biopsies, complicating the decision-making process for both healthcare providers and patients when determining appropriate treatment strategies.

Market Trends of the Global Breast Biopsy Market

A notable trend in the global breast biopsy market is the rising preference for image-guided biopsy techniques, including ultrasound, mammography, and MRI-guided biopsies. These advanced methods have gained traction due to their enhanced ability to precisely locate and sample suspicious breast lesions, thereby increasing diagnostic accuracy and minimizing invasiveness compared to traditional approaches. Real-time imaging allows for superior visualization, leading to higher diagnostic yields and reducing the likelihood of repeat procedures. This shift towards image-guided biopsies underscores the industry's commitment to improving the accuracy and efficiency of breast biopsy protocols, while also emphasizing patient comfort and minimizing procedural risks. As a result, this trend is poised to shape future developments in breast cancer diagnostics and intervention.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Breast Biopsy Market Size by Product & CAGR (2024-2031)

• Market Overview
• Biopsy Needles
  • Core Needles
  • Fine Aspiration Needles
• Mri Guide Biopsy Systems
• Ultrasound Guided Breast Biopsy System
  • 2D Mammographic Ultrasonic Scanning Systems
  • 3D B-Mode Mammographic Ultrasonic Scanning Systems
• Vacuum Assisted Devices
• Guide Wire
• Breast Biopsy Markers

Global Breast Biopsy Market Size by Indication & CAGR (2024-2031)

• Market Overview
• Complex Cysts
• Solid Mass
• Suspicious Solid Mass
• Suspicious Micro Calcifications

Global Breast Biopsy Market Size by End User & CAGR (2024-2031)

• Market Overview
• Hospitals
• Specialty Clinics
• Cancer Research Institutes

Global Breast Biopsy Market Size & CAGR (2024-2031)

• North America (Product, Indication, End User)
  • USA
  • Canada
• Europe (Product, Indication, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Indication, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Indication, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Indication, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Hologic, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Argon Medical Devices (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merit Medical Systems (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Menarini-Silicon Biosystems (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Guardant Health, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeoGenomics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Inostics (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ethicon Endo-Surgery, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• C. R. Bard, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Leica Biosystems Nussloch GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Encapsule Medical Devices LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intact Medical Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Galini SRL (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Devicor Medical Products, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Carestream Health, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Planmed Oy (Finland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations